Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group

'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2016-08, Vol.11 (8), p.e0160767-e0160767
Hauptverfasser: Sasaki, Tsuyoshi, Hashimoto, Kenji, Oda, Yasunori, Ishima, Tamaki, Yakita, Madoka, Kurata, Tsutomu, Kunou, Masaru, Takahashi, Jumpei, Kamata, Yu, Kimura, Atsushi, Niitsu, Tomihisa, Komatsu, Hideki, Hasegawa, Tadashi, Shiina, Akihiro, Hashimoto, Tasuku, Kanahara, Nobuhisa, Shimizu, Eiji, Iyo, Masaomi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0160767
container_issue 8
container_start_page e0160767
container_title PloS one
container_volume 11
creator Sasaki, Tsuyoshi
Hashimoto, Kenji
Oda, Yasunori
Ishima, Tamaki
Yakita, Madoka
Kurata, Tsutomu
Kunou, Masaru
Takahashi, Jumpei
Kamata, Yu
Kimura, Atsushi
Niitsu, Tomihisa
Komatsu, Hideki
Hasegawa, Tadashi
Shiina, Akihiro
Hashimoto, Tasuku
Kanahara, Nobuhisa
Shimizu, Eiji
Iyo, Masaomi
description 'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this study was to determine whether serum levels of oxytocin (OXT) in treatment-resistant depression in adolescents (TRDIA) differ from non-treatment-resistant depression in adolescents (non-TRDIA) or controls. We also investigated the relationships between serum OXT levels and the clinical symptoms, severity, and familial histories of adolescent depressive patients. We measured serum OXT levels: TRDIA (n = 10), non-TRDIA (n = 27), and age- and sex- matched, neurotypical controls (n = 25). Patients were evaluated using the Children's Depression Rating Scale-Revised (CDRS-R) and the Depression Self-Rating Scale for Children-Japanese Version (DSRS-C-J). The patients were also assessed retrospectively using the following variables: familial history of major depressive disorder and BD (1st degree or 2nd degree), history of disruptive mood dysregulation disorder, recurrent depressive disorder (RDD), history of antidepressant activation. Serum levels of OXT among the TRDIA and non-TRDIA patients and controls differed significantly. Interestingly, the rates of a family history of BD (1st or 2nd degree), RDD and a history of antidepressant activation in our TRDIA group were significantly higher than those of the non-TRDIA group. Serum levels of OXT may play a role in the pathophysiology of TRDIA.
doi_str_mv 10.1371/journal.pone.0160767
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1812823467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A461034643</galeid><doaj_id>oai_doaj_org_article_ab23f6116c9e4f3c8c164e054ef85193</doaj_id><sourcerecordid>A461034643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791t-2b895b568ae01e5eb5fe8f789168f3f959e3bced0768b728ba4894e4caf798433</originalsourceid><addsrcrecordid>eNqNk9Fq2zAUhs3YWLtubzA2w2BtL5JJlixLN4PQbl0gEEiz3QpZPkocbCuT7NK-_ZTELfHoRZFAQvrOL51fOlH0EaMxJhn-trGda1Q13toGxggzlLHsVXSKBUlGLEHk9dH8JHrn_QahlHDG3kYnSZYSlvH0NNLTRjtQHor4FlxXxzO4g8rH1sTz-4fW6rKJQz9fBqitoWnjBfjStyrMrmHrwPvS7pFJYSvwOiA-vlgurqeTy_P4xtlu-z56Y1Tl4UM_nkW_f_5YXv0azeY306vJbKQzgdtRknOR5injChCGFPLUADcZF5hxQ4xIBZBcQxES5XmW8FxRLihQrUwmOCXkLPp80N1W1sveHy8xxwlPCGVZIKYHorBqI7eurJV7kFaVcr9g3Uoq15a6AqnyhBiGMdMCqCGaa8wooJSC4WkwNmh970_r8hqKXeJOVQPR4U5TruXK3kkqBKIYB4GLXsDZvx34VtZl8K-qVAO22987ZSLkiF6CJpyzhNKAfvkPfd6InlqpkGvZGBuuqHeickIZRgHaGzp-hgqtgLrU4d-ZMqwPAi4HAYFp4b5dqc57Ob1dvJyd_xmyX4_YNaiqXXtbdW34e34I0gOonfXegXl6D4zkrmwe3ZC7spF92YSwT8dv-RT0WCfkH-QwEFk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1812823467</pqid></control><display><type>article</type><title>Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Sasaki, Tsuyoshi ; Hashimoto, Kenji ; Oda, Yasunori ; Ishima, Tamaki ; Yakita, Madoka ; Kurata, Tsutomu ; Kunou, Masaru ; Takahashi, Jumpei ; Kamata, Yu ; Kimura, Atsushi ; Niitsu, Tomihisa ; Komatsu, Hideki ; Hasegawa, Tadashi ; Shiina, Akihiro ; Hashimoto, Tasuku ; Kanahara, Nobuhisa ; Shimizu, Eiji ; Iyo, Masaomi</creator><contributor>Zhang, Xiang Yang</contributor><creatorcontrib>Sasaki, Tsuyoshi ; Hashimoto, Kenji ; Oda, Yasunori ; Ishima, Tamaki ; Yakita, Madoka ; Kurata, Tsutomu ; Kunou, Masaru ; Takahashi, Jumpei ; Kamata, Yu ; Kimura, Atsushi ; Niitsu, Tomihisa ; Komatsu, Hideki ; Hasegawa, Tadashi ; Shiina, Akihiro ; Hashimoto, Tasuku ; Kanahara, Nobuhisa ; Shimizu, Eiji ; Iyo, Masaomi ; Zhang, Xiang Yang</creatorcontrib><description>'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this study was to determine whether serum levels of oxytocin (OXT) in treatment-resistant depression in adolescents (TRDIA) differ from non-treatment-resistant depression in adolescents (non-TRDIA) or controls. We also investigated the relationships between serum OXT levels and the clinical symptoms, severity, and familial histories of adolescent depressive patients. We measured serum OXT levels: TRDIA (n = 10), non-TRDIA (n = 27), and age- and sex- matched, neurotypical controls (n = 25). Patients were evaluated using the Children's Depression Rating Scale-Revised (CDRS-R) and the Depression Self-Rating Scale for Children-Japanese Version (DSRS-C-J). The patients were also assessed retrospectively using the following variables: familial history of major depressive disorder and BD (1st degree or 2nd degree), history of disruptive mood dysregulation disorder, recurrent depressive disorder (RDD), history of antidepressant activation. Serum levels of OXT among the TRDIA and non-TRDIA patients and controls differed significantly. Interestingly, the rates of a family history of BD (1st or 2nd degree), RDD and a history of antidepressant activation in our TRDIA group were significantly higher than those of the non-TRDIA group. Serum levels of OXT may play a role in the pathophysiology of TRDIA.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0160767</identifier><identifier>PMID: 27536785</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Activation ; Adolescent ; Adolescents ; Antidepressants ; Antidepressive Agents - therapeutic use ; Biology and Life Sciences ; Bipolar disorder ; Children ; Depressive Disorder, Treatment-Resistant - blood ; Depressive Disorder, Treatment-Resistant - drug therapy ; Drug therapy ; Evidence-based medicine ; Female ; Genetics ; Health aspects ; Humans ; Male ; Measurement methods ; Medicine and Health Sciences ; Mental depression ; Mood ; Oxytocin ; Oxytocin - blood ; Patients ; People and Places ; Physiological aspects ; Psychological aspects ; Retrospective Studies ; Risk factors ; Serum levels ; Social Sciences ; Suicides &amp; suicide attempts ; Teenagers</subject><ispartof>PloS one, 2016-08, Vol.11 (8), p.e0160767-e0160767</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Sasaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Sasaki et al 2016 Sasaki et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c791t-2b895b568ae01e5eb5fe8f789168f3f959e3bced0768b728ba4894e4caf798433</citedby><cites>FETCH-LOGICAL-c791t-2b895b568ae01e5eb5fe8f789168f3f959e3bced0768b728ba4894e4caf798433</cites><orcidid>0000-0001-8502-6469</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990411/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990411/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27536785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Zhang, Xiang Yang</contributor><creatorcontrib>Sasaki, Tsuyoshi</creatorcontrib><creatorcontrib>Hashimoto, Kenji</creatorcontrib><creatorcontrib>Oda, Yasunori</creatorcontrib><creatorcontrib>Ishima, Tamaki</creatorcontrib><creatorcontrib>Yakita, Madoka</creatorcontrib><creatorcontrib>Kurata, Tsutomu</creatorcontrib><creatorcontrib>Kunou, Masaru</creatorcontrib><creatorcontrib>Takahashi, Jumpei</creatorcontrib><creatorcontrib>Kamata, Yu</creatorcontrib><creatorcontrib>Kimura, Atsushi</creatorcontrib><creatorcontrib>Niitsu, Tomihisa</creatorcontrib><creatorcontrib>Komatsu, Hideki</creatorcontrib><creatorcontrib>Hasegawa, Tadashi</creatorcontrib><creatorcontrib>Shiina, Akihiro</creatorcontrib><creatorcontrib>Hashimoto, Tasuku</creatorcontrib><creatorcontrib>Kanahara, Nobuhisa</creatorcontrib><creatorcontrib>Shimizu, Eiji</creatorcontrib><creatorcontrib>Iyo, Masaomi</creatorcontrib><title>Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this study was to determine whether serum levels of oxytocin (OXT) in treatment-resistant depression in adolescents (TRDIA) differ from non-treatment-resistant depression in adolescents (non-TRDIA) or controls. We also investigated the relationships between serum OXT levels and the clinical symptoms, severity, and familial histories of adolescent depressive patients. We measured serum OXT levels: TRDIA (n = 10), non-TRDIA (n = 27), and age- and sex- matched, neurotypical controls (n = 25). Patients were evaluated using the Children's Depression Rating Scale-Revised (CDRS-R) and the Depression Self-Rating Scale for Children-Japanese Version (DSRS-C-J). The patients were also assessed retrospectively using the following variables: familial history of major depressive disorder and BD (1st degree or 2nd degree), history of disruptive mood dysregulation disorder, recurrent depressive disorder (RDD), history of antidepressant activation. Serum levels of OXT among the TRDIA and non-TRDIA patients and controls differed significantly. Interestingly, the rates of a family history of BD (1st or 2nd degree), RDD and a history of antidepressant activation in our TRDIA group were significantly higher than those of the non-TRDIA group. Serum levels of OXT may play a role in the pathophysiology of TRDIA.</description><subject>Activation</subject><subject>Adolescent</subject><subject>Adolescents</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Biology and Life Sciences</subject><subject>Bipolar disorder</subject><subject>Children</subject><subject>Depressive Disorder, Treatment-Resistant - blood</subject><subject>Depressive Disorder, Treatment-Resistant - drug therapy</subject><subject>Drug therapy</subject><subject>Evidence-based medicine</subject><subject>Female</subject><subject>Genetics</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Male</subject><subject>Measurement methods</subject><subject>Medicine and Health Sciences</subject><subject>Mental depression</subject><subject>Mood</subject><subject>Oxytocin</subject><subject>Oxytocin - blood</subject><subject>Patients</subject><subject>People and Places</subject><subject>Physiological aspects</subject><subject>Psychological aspects</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Serum levels</subject><subject>Social Sciences</subject><subject>Suicides &amp; suicide attempts</subject><subject>Teenagers</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9Fq2zAUhs3YWLtubzA2w2BtL5JJlixLN4PQbl0gEEiz3QpZPkocbCuT7NK-_ZTELfHoRZFAQvrOL51fOlH0EaMxJhn-trGda1Q13toGxggzlLHsVXSKBUlGLEHk9dH8JHrn_QahlHDG3kYnSZYSlvH0NNLTRjtQHor4FlxXxzO4g8rH1sTz-4fW6rKJQz9fBqitoWnjBfjStyrMrmHrwPvS7pFJYSvwOiA-vlgurqeTy_P4xtlu-z56Y1Tl4UM_nkW_f_5YXv0azeY306vJbKQzgdtRknOR5injChCGFPLUADcZF5hxQ4xIBZBcQxES5XmW8FxRLihQrUwmOCXkLPp80N1W1sveHy8xxwlPCGVZIKYHorBqI7eurJV7kFaVcr9g3Uoq15a6AqnyhBiGMdMCqCGaa8wooJSC4WkwNmh970_r8hqKXeJOVQPR4U5TruXK3kkqBKIYB4GLXsDZvx34VtZl8K-qVAO22987ZSLkiF6CJpyzhNKAfvkPfd6InlqpkGvZGBuuqHeickIZRgHaGzp-hgqtgLrU4d-ZMqwPAi4HAYFp4b5dqc57Ob1dvJyd_xmyX4_YNaiqXXtbdW34e34I0gOonfXegXl6D4zkrmwe3ZC7spF92YSwT8dv-RT0WCfkH-QwEFk</recordid><startdate>20160818</startdate><enddate>20160818</enddate><creator>Sasaki, Tsuyoshi</creator><creator>Hashimoto, Kenji</creator><creator>Oda, Yasunori</creator><creator>Ishima, Tamaki</creator><creator>Yakita, Madoka</creator><creator>Kurata, Tsutomu</creator><creator>Kunou, Masaru</creator><creator>Takahashi, Jumpei</creator><creator>Kamata, Yu</creator><creator>Kimura, Atsushi</creator><creator>Niitsu, Tomihisa</creator><creator>Komatsu, Hideki</creator><creator>Hasegawa, Tadashi</creator><creator>Shiina, Akihiro</creator><creator>Hashimoto, Tasuku</creator><creator>Kanahara, Nobuhisa</creator><creator>Shimizu, Eiji</creator><creator>Iyo, Masaomi</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8502-6469</orcidid></search><sort><creationdate>20160818</creationdate><title>Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group</title><author>Sasaki, Tsuyoshi ; Hashimoto, Kenji ; Oda, Yasunori ; Ishima, Tamaki ; Yakita, Madoka ; Kurata, Tsutomu ; Kunou, Masaru ; Takahashi, Jumpei ; Kamata, Yu ; Kimura, Atsushi ; Niitsu, Tomihisa ; Komatsu, Hideki ; Hasegawa, Tadashi ; Shiina, Akihiro ; Hashimoto, Tasuku ; Kanahara, Nobuhisa ; Shimizu, Eiji ; Iyo, Masaomi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791t-2b895b568ae01e5eb5fe8f789168f3f959e3bced0768b728ba4894e4caf798433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Activation</topic><topic>Adolescent</topic><topic>Adolescents</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Biology and Life Sciences</topic><topic>Bipolar disorder</topic><topic>Children</topic><topic>Depressive Disorder, Treatment-Resistant - blood</topic><topic>Depressive Disorder, Treatment-Resistant - drug therapy</topic><topic>Drug therapy</topic><topic>Evidence-based medicine</topic><topic>Female</topic><topic>Genetics</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Male</topic><topic>Measurement methods</topic><topic>Medicine and Health Sciences</topic><topic>Mental depression</topic><topic>Mood</topic><topic>Oxytocin</topic><topic>Oxytocin - blood</topic><topic>Patients</topic><topic>People and Places</topic><topic>Physiological aspects</topic><topic>Psychological aspects</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Serum levels</topic><topic>Social Sciences</topic><topic>Suicides &amp; suicide attempts</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sasaki, Tsuyoshi</creatorcontrib><creatorcontrib>Hashimoto, Kenji</creatorcontrib><creatorcontrib>Oda, Yasunori</creatorcontrib><creatorcontrib>Ishima, Tamaki</creatorcontrib><creatorcontrib>Yakita, Madoka</creatorcontrib><creatorcontrib>Kurata, Tsutomu</creatorcontrib><creatorcontrib>Kunou, Masaru</creatorcontrib><creatorcontrib>Takahashi, Jumpei</creatorcontrib><creatorcontrib>Kamata, Yu</creatorcontrib><creatorcontrib>Kimura, Atsushi</creatorcontrib><creatorcontrib>Niitsu, Tomihisa</creatorcontrib><creatorcontrib>Komatsu, Hideki</creatorcontrib><creatorcontrib>Hasegawa, Tadashi</creatorcontrib><creatorcontrib>Shiina, Akihiro</creatorcontrib><creatorcontrib>Hashimoto, Tasuku</creatorcontrib><creatorcontrib>Kanahara, Nobuhisa</creatorcontrib><creatorcontrib>Shimizu, Eiji</creatorcontrib><creatorcontrib>Iyo, Masaomi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sasaki, Tsuyoshi</au><au>Hashimoto, Kenji</au><au>Oda, Yasunori</au><au>Ishima, Tamaki</au><au>Yakita, Madoka</au><au>Kurata, Tsutomu</au><au>Kunou, Masaru</au><au>Takahashi, Jumpei</au><au>Kamata, Yu</au><au>Kimura, Atsushi</au><au>Niitsu, Tomihisa</au><au>Komatsu, Hideki</au><au>Hasegawa, Tadashi</au><au>Shiina, Akihiro</au><au>Hashimoto, Tasuku</au><au>Kanahara, Nobuhisa</au><au>Shimizu, Eiji</au><au>Iyo, Masaomi</au><au>Zhang, Xiang Yang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-08-18</date><risdate>2016</risdate><volume>11</volume><issue>8</issue><spage>e0160767</spage><epage>e0160767</epage><pages>e0160767-e0160767</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this study was to determine whether serum levels of oxytocin (OXT) in treatment-resistant depression in adolescents (TRDIA) differ from non-treatment-resistant depression in adolescents (non-TRDIA) or controls. We also investigated the relationships between serum OXT levels and the clinical symptoms, severity, and familial histories of adolescent depressive patients. We measured serum OXT levels: TRDIA (n = 10), non-TRDIA (n = 27), and age- and sex- matched, neurotypical controls (n = 25). Patients were evaluated using the Children's Depression Rating Scale-Revised (CDRS-R) and the Depression Self-Rating Scale for Children-Japanese Version (DSRS-C-J). The patients were also assessed retrospectively using the following variables: familial history of major depressive disorder and BD (1st degree or 2nd degree), history of disruptive mood dysregulation disorder, recurrent depressive disorder (RDD), history of antidepressant activation. Serum levels of OXT among the TRDIA and non-TRDIA patients and controls differed significantly. Interestingly, the rates of a family history of BD (1st or 2nd degree), RDD and a history of antidepressant activation in our TRDIA group were significantly higher than those of the non-TRDIA group. Serum levels of OXT may play a role in the pathophysiology of TRDIA.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27536785</pmid><doi>10.1371/journal.pone.0160767</doi><tpages>e0160767</tpages><orcidid>https://orcid.org/0000-0001-8502-6469</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-08, Vol.11 (8), p.e0160767-e0160767
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1812823467
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Activation
Adolescent
Adolescents
Antidepressants
Antidepressive Agents - therapeutic use
Biology and Life Sciences
Bipolar disorder
Children
Depressive Disorder, Treatment-Resistant - blood
Depressive Disorder, Treatment-Resistant - drug therapy
Drug therapy
Evidence-based medicine
Female
Genetics
Health aspects
Humans
Male
Measurement methods
Medicine and Health Sciences
Mental depression
Mood
Oxytocin
Oxytocin - blood
Patients
People and Places
Physiological aspects
Psychological aspects
Retrospective Studies
Risk factors
Serum levels
Social Sciences
Suicides & suicide attempts
Teenagers
title Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A41%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Serum%20Levels%20of%20Oxytocin%20in%20'Treatment%20Resistant%20Depression%20in%20Adolescents%20(TRDIA)'%20Group&rft.jtitle=PloS%20one&rft.au=Sasaki,%20Tsuyoshi&rft.date=2016-08-18&rft.volume=11&rft.issue=8&rft.spage=e0160767&rft.epage=e0160767&rft.pages=e0160767-e0160767&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0160767&rft_dat=%3Cgale_plos_%3EA461034643%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1812823467&rft_id=info:pmid/27536785&rft_galeid=A461034643&rft_doaj_id=oai_doaj_org_article_ab23f6116c9e4f3c8c164e054ef85193&rfr_iscdi=true